Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2025-12-25 @ 9:09 PM
NCT ID: NCT03326856
Description: None
Frequency Threshold: 5
Time Frame: 26 Weeks
Study: NCT03326856
Study Brief: ET-01 in Subjects With Lateral Canthal Lines
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Vehicle Vehicle Vehicle: Vehicle Formulation 0 None 0 13 0 13 View
Dose 1 botulinum toxin, Type A, topical liniment Dose 1x on Day 0 0 None 0 9 0 9 View
Dose 2 botulinum toxin, Type A, topical liniment Dose 1.8x on Day 0 0 None 0 9 1 9 View
Dose 3 botulinum toxin, Type A, topical liniment Dose 2.5x on Day 0 0 None 0 9 0 9 View
Dose 4 botulinum toxin, Type A, topical liniment Dose 3.5x on Day 0 0 None 0 8 1 8 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Basal cell carcinoma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA, version 13.1 View
Myocardial infarction SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA, version 13.1 View